Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1991 Dec;23(6):873-88.
doi: 10.1007/BF00786006.

Regulation of the mitochondrial ATPase in situ in cardiac muscle: role of the inhibitor subunit

Affiliations
Review

Regulation of the mitochondrial ATPase in situ in cardiac muscle: role of the inhibitor subunit

W Rouslin. J Bioenerg Biomembr. 1991 Dec.

Abstract

The mitochondrial F1-ATPase inhibitor protein, IF1, binds to beta subunits of the F1-ATPase both in vitro and in situ under nonenergizing conditions, i.e., under conditions that allow a net hydrolysis of ATP by the mitochondrial ATPase to take place. This reversible IF1 binding occurs in a wide variety of cell types including (anaerobic) baker's yeast cells and (ischemic) mammalian cardiomyocytes under conditions that limit oxidative phosphorylation. The binding of inhibitor results in a marked slowing of ATP hydrolysis by the undriven mitochondrial ATP synthase. An apparent main function of this reversible IF1 binding, at least in cells that undergo aerobic-anaerobic switching, is the mitigation of a wasteful hydrolysis of ATP produced by glycolysis during anoxic or ischemic intervals, by the mitochondrial ATPase. While this apparent main function is probably of considerable importance in cells that normally either can or must undergo aerobic-anaerobic switching such as baker's yeast cells and skeletal myocytes, one wonders why a full complement of IF1 has been retained in certain cells that normally do not undergo such aerobic-anaerobic switching, cells such as adult mammalian cardiomyocytes of many species. While some mammalian species have, indeed, not retained a functional complement of IF1 in their cardiomyocytes, those that have can benefit significantly from its presence during intervals of myocardial ischemia.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Annu Rev Med. 1991;42:225-46 - PubMed
    1. J Biol Chem. 1990 Apr 15;265(11):6274-8 - PubMed
    1. J Mol Cell Cardiol. 1984 May;16(5):439-47 - PubMed
    1. Rev Physiol Biochem Pharmacol. 1985;102:1-72 - PubMed
    1. Biochem J. 1976 Nov 15;160(2):335-42 - PubMed

Publication types

MeSH terms